Details of the Drug

General Information of Drug (ID: DMAWLB4)

Drug Name

Lpathomab

Synonyms

Anti-lysophosphatidic acid (LPA) monoclonal antibody (cancer/neuropathic pain/fibrosis/ocular inflammation), Lpath

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Monoclonal antibody

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02341508) A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Lpathomab inSubjects With Neuropathic Pain. U.S. National Institutes of Health.